Sevoflurane Liquid
Product Images NDC 72162-2245

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sevoflurane (NDC 72162-2245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622245)

Label for Sevoflurane USP inhalation anesthetic liquid, concentration 1 mL in 1 mL, in a 250 mL container. The label includes storage instructions, a QR code, barcodes, and states it is relabeled by Bryant Ranch Prepack, Inc. and manufactured by Piramal Critical Care, Inc. The product NDC on the label is 72162-2245-2.*

FDA Label Image

Figure1 (Sevo Fig1)

A line graph titled 'Fresh Gas Flow Rate versus Compound A Levels in a Circle Absorber System' showing a decrease in Compound A levels (in ppm) as fresh gas flow rate (L/min) increases from 0.5 to 3 L/min, with a slight increase at 4 L/min. The x-axis represents fresh gas flow rate, and the y-axis represents Compound A concentration.*

FDA Label Image

Sevo-fig10 (Sevo Fig10)

A line graph titled 'Figure 10: Cardiac Index' displaying cardiac index values (L/min/m²) on the vertical axis against MAC levels on the horizontal axis, including baseline. Two data series are shown: one with Sevoflurane in O₂ and another with Sevoflurane in O₂/N₂O, each with error bars indicating variability.*

FDA Label Image

Figure2 (Sevo Fig2)

A line graph titled 'Carbon Dioxide Flow Versus Compound A and Maximum Temperature' plotting Carbon Dioxide Flow in mL/min (x-axis) against Compound A concentration in ppm and Maximum Temperature in degrees Celsius (y-axis). Two data lines are shown: Compound A (ppm) represented by circles, and Maximum Temperature (°C) represented by squares, both increasing with higher carbon dioxide flow rates.*

FDA Label Image

Figure2a (Sevo Fig2a)

A scatter plot with a linear trend line illustrating the relationship between sevoflurane exposure measured in MAC-hours on the x-axis and the inspired compound area under the curve (AUC) in ppm-hours on the y-axis, at a flow rate of 1 L/min. The plot shows a strong positive correlation (r=0.96, p<0.001).*

FDA Label Image

Sevo-fig3 (Sevo Fig3)

A line graph titled 'Ratio of Concentration of Anesthetic in Alveolar Gas to Inspired Gas' shows the ratio (F_A/F_I) on the vertical axis from 0 to 1, and minutes of administration on the horizontal axis from 0 to 40. It compares five anesthetics: Halothane, Isoflurane, Sevoflurane, Desflurane, and N2O, each represented by different line styles and markers, illustrating their concentration ratios over time during administration.*

FDA Label Image

Sevo-fig4 (Sevo Fig4)

A line graph titled 'Concentration of Anesthetic in Alveolar Gas Following Termination of Anesthesia' showing the ratio of alveolar to inspired concentration (FA/FA0) over time in minutes. The graph compares elimination curves for Halothane, Isoflurane, Sevoflurane, Desflurane, and N2O from 0 to 120 minutes.*

FDA Label Image

Sevo-fig5 (Sevo Fig5)

A line graph showing serum inorganic fluoride concentrations over time (days post-anesthesia) for sevoflurane and other volatile anesthetics including methoxyflurane, enflurane, isoflurane, and halothane. The y-axis represents serum fluoride concentration in micromolar (µM), ranging from 0 to 70, and the x-axis shows days from pre-anesthesia to 6 days post-anesthesia. Data points for each anesthetic are indicated with distinct symbols and include sample sizes.*

FDA Label Image

Sevo-fig6 (Sevo Fig6)

A line graph titled 'Fluoride Ion Concentrations Following Administration of Sevoflurane' showing fluoride ion concentration (µM) on the y-axis versus time (hours) on the x-axis. Four lines represent mean concentration, mean concentration plus one, two, and three standard deviations over a 50-hour period following Sevoflurane administration.*

FDA Label Image

Sevo-fig7 (Sevo Fig7)

A line graph titled 'Figure 7: Heart Rate' showing heart rate in beats per minute on the vertical axis and MAC level on the horizontal axis. Two series are plotted: one labeled 'A - Sevo/O2' represented by diamonds, and another labeled 'C - Sevo/O2/N2O' represented by triangles, each with error bars, depicting heart rate changes over increasing MAC levels from baseline to 2.5.*

FDA Label Image

Sevo-fig8 (Sevo Fig8)

A line graph titled "Figure 8: Mean Arterial Pressure" showing mmHg on the y-axis and MAC level on the x-axis. The graph compares two groups labeled A (Sevo/O2) and C (Sevo/O2/N2O), with data points illustrating mean arterial pressure changes from baseline through increasing MAC levels, including error bars for variability.*

FDA Label Image

Sevo-fig9 (Sevo Fig9)

A line graph titled 'Figure 9: Systemic Vascular Resistance' showing systemic vascular resistance (dynes·sec·cm⁻⁵) on the y-axis versus MAC Level on the x-axis. The graph compares two groups: A (Sevo/oxygen) and C (Sevo/oxygen/nitrous oxide), with data points plotted for baseline and increasing MAC levels, illustrating a decrease in vascular resistance as MAC level increases, with error bars for variability.*

FDA Label Image

Structure (Sevo Structure)

Chemical structure of Sevoflurane, showing its molecular formula with trifluoromethyl groups (CF3) attached to a central carbon, along with a fluoromethyl ether group (OCH2F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.